Haba Laboratories

Haba Laboratories Financial Leverage

The Financial Leverage (Equity Multiplier) of Haba Laboratories (4925.T) as of Oct 18, 2026 is 1.31. In the previous year, Financial Leverage (Equity Multiplier) was 1.38 — a change of -5.06% (lower).

Financial Leverage

1.31

YoY

-5.06%

Last updated:

Financial Leverage (Equity Multiplier) of Haba Laboratories is 2026 1.31 . Financial Leverage (Equity Multiplier) of Haba Laboratories was 2025 1.38 . It decreases by -5.06% lower compared to the previous year.

The Haba Laboratories Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
1.38 JPY
Jan 1, 2020
1.43 JPY
Jan 1, 2021
1.46 JPY
Jan 1, 2022
1.35 JPY
Jan 1, 2023
1.37 JPY
Jan 1, 2024
1.46 JPY
Jan 1, 2025
1.38 JPY
Jan 1, 2026
1.31 JPY
The Haba Laboratories Financial Leverage history
YEARFinancial LeverageYoY
1.31-5.06%
1.38-5.37%
1.46+6.86%
1.37+0.97%
1.35-6.93%
1.46+1.52%
1.43+3.86%
1.38-9.59%
1.53-3.93%
1.59-8.44%
1.74-14.73%
2.04-5.23%
2.15—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haba Laboratories Stock analysis

What does Haba Laboratories do? Haba Laboratories Inc, listed on the Tokyo Stock Exchange with ticker 4925.T and ISIN JP3765130004, is a Japanese company operating in the Consumer Staples sector under the Consumer products industry. Headquartered in Chiyoda-ku, Tokyo, the company employs 654 people. It went public on June 11, 2003. Haba Laboratories focuses on the development, manufacture, and sale of natural cosmetics, quasi-drugs, and nutritional supplements. The company distributes its products through wholesale channels to department stores, retailers, and wholesalers, as well as via mail order services to individual customers. It also operates its own retail stores for direct sales. The firm's product range includes cosmetics for both women and men, with an emphasis on natural formulations. Haba Laboratories maintains a website at http://www.haba.com/ for customer and investor information. The company's operations are based in Japan, reflecting its domestic market focus within the consumer goods sector. Its business model combines B2B wholesale distribution with direct-to-consumer sales channels, supporting a diversified revenue stream across multiple retail touchpoints. Haba Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Haba Laboratories stock

Financial Leverage (Equity Multiplier) of Haba Laboratories is 1.31 in 2026.

Financial Leverage (Equity Multiplier) of Haba Laboratories changed from 1.38 to 1.31, representing a -5.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Haba Laboratories since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Haba Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Haba Laboratories

All Key Metrics — Haba Laboratories